Schedule 13D ownership disclosure
ASCENDIS PHARMA A/S
Security class unavailable · CUSIP: 04351P101
Event date: 2018-02-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,799,112
- Percent of class
- 4.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001615774-18-001581
- Form type
- SC 13D
- Filer
- Ascendis Pharma A/S
- CIK
- CIK 1612042
- Filed
- Mar 02, 2018
- Reporting period
- Feb 26, 2018
- Description
- Schedule 13D beneficial ownership